269 related articles for article (PubMed ID: 34158842)
1. IRDye800CW labeled uPAR-targeting peptide for fluorescence-guided glioblastoma surgery: Preclinical studies in orthotopic xenografts.
Kurbegovic S; Juhl K; Sørensen KK; Leth J; Willemoe GL; Christensen A; Adams Y; Jensen AR; von Buchwald C; Skjøth-Rasmussen J; Ploug M; Jensen KJ; Kjaer A
Theranostics; 2021; 11(15):7159-7174. PubMed ID: 34158842
[TBL] [Abstract][Full Text] [Related]
2. Molecular Targeted NIR-II Probe for Image-Guided Brain Tumor Surgery.
Kurbegovic S; Juhl K; Chen H; Qu C; Ding B; Leth JM; Drzewiecki KT; Kjaer A; Cheng Z
Bioconjug Chem; 2018 Nov; 29(11):3833-3840. PubMed ID: 30296054
[TBL] [Abstract][Full Text] [Related]
3. First-in-human study of PET and optical dual-modality image-guided surgery in glioblastoma using
Li D; Zhang J; Chi C; Xiao X; Wang J; Lang L; Ali I; Niu G; Zhang L; Tian J; Ji N; Zhu Z; Chen X
Theranostics; 2018; 8(9):2508-2520. PubMed ID: 29721096
[No Abstract] [Full Text] [Related]
4. Side-by-Side Comparison of uPAR-Targeting Optical Imaging Antibodies and Antibody Fragments for Fluorescence-Guided Surgery of Solid Tumors.
Baart VM; van Manen L; Bhairosingh SS; Vuijk FA; Iamele L; de Jonge H; Scotti C; Resnati M; Cordfunke RA; Kuppen PJK; Mazar AP; Burggraaf J; Vahrmeijer AL; Sier CFM
Mol Imaging Biol; 2023 Feb; 25(1):122-132. PubMed ID: 34642899
[TBL] [Abstract][Full Text] [Related]
5. Peptide-Based Optical uPAR Imaging for Surgery: In Vivo Testing of ICG-Glu-Glu-AE105.
Juhl K; Christensen A; Persson M; Ploug M; Kjaer A
PLoS One; 2016; 11(2):e0147428. PubMed ID: 26828431
[TBL] [Abstract][Full Text] [Related]
6. A multimodal molecular imaging approach targeting urokinase plasminogen activator receptor for the diagnosis, resection and surveillance of urothelial cell carcinoma.
Baart VM; van der Horst G; Deken MM; Bhairosingh SS; Schomann T; Sier VQ; van der Mark MH; Iamele L; de Jonge H; Resnati M; Mazar AP; Pelger RCM; van der Pluijm G; Kuppen PJK; Vahrmeijer AL; Sier CFM
Eur J Cancer; 2021 Mar; 146():11-20. PubMed ID: 33561783
[TBL] [Abstract][Full Text] [Related]
7. uPAR-targeted optical imaging contrasts as theranostic agents for tumor margin detection.
Yang L; Sajja HK; Cao Z; Qian W; Bender L; Marcus AI; Lipowska M; Wood WC; Wang YA
Theranostics; 2013; 4(1):106-18. PubMed ID: 24396518
[TBL] [Abstract][Full Text] [Related]
8. uPAR-targeted optical near-infrared (NIR) fluorescence imaging and PET for image-guided surgery in head and neck cancer: proof-of-concept in orthotopic xenograft model.
Christensen A; Juhl K; Persson M; Charabi BW; Mortensen J; Kiss K; Lelkaitis G; Rubek N; von Buchwald C; Kjær A
Oncotarget; 2017 Feb; 8(9):15407-15419. PubMed ID: 28039488
[TBL] [Abstract][Full Text] [Related]
9. DOT corrected fluorescence molecular tomography using targeted contrast agents for small animal tumor imaging.
Tan Y; Cao Z; Sajja HK; Lipowska M; Wang YA; Yang L; Jiang H
J Xray Sci Technol; 2013; 21(1):43-52. PubMed ID: 23507851
[TBL] [Abstract][Full Text] [Related]
10. Improved positron emission tomography imaging of glioblastoma cancer using novel
Loft MD; Sun Y; Liu C; Christensen C; Huang D; Kjaer A; Cheng Z
Amino Acids; 2017 Jun; 49(6):1089-1100. PubMed ID: 28316028
[TBL] [Abstract][Full Text] [Related]
11. Development of a Novel Histone Deacetylase-Targeted Near-Infrared Probe for Hepatocellular Carcinoma Imaging and Fluorescence Image-Guided Surgery.
Tang C; Du Y; Liang Q; Cheng Z; Tian J
Mol Imaging Biol; 2020 Jun; 22(3):476-485. PubMed ID: 31228075
[TBL] [Abstract][Full Text] [Related]
12. A novel urokinase plasminogen activator receptor-targeted peptide-based probe for in-vivo molecular imaging of glioblastoma.
Han Y; Tu L; Zhang Y; Xu L; Sun Z
Nucl Med Commun; 2023 Feb; 44(2):142-149. PubMed ID: 36630218
[TBL] [Abstract][Full Text] [Related]
13. NIR-II fluorescence-guided liver cancer surgery by a small molecular HDAC6 targeting probe.
Wang B; Tang C; Lin E; Jia X; Xie G; Li P; Li D; Yang Q; Guo X; Cao C; Shi X; Zou B; Cai C; Tian J; Hu Z; Li J
EBioMedicine; 2023 Dec; 98():104880. PubMed ID: 38035463
[TBL] [Abstract][Full Text] [Related]
14. Near-Infrared Dye-Labeled Anti-Prostate Stem Cell Antigen Minibody Enables Real-Time Fluorescence Imaging and Targeted Surgery in Translational Mouse Models.
Zhang M; Kobayashi N; Zettlitz KA; Kono EA; Yamashiro JM; Tsai WK; Jiang ZK; Tran CP; Wang C; Guan J; Wu AM; Reiter RE
Clin Cancer Res; 2019 Jan; 25(1):188-200. PubMed ID: 30301826
[TBL] [Abstract][Full Text] [Related]
15. Urokinase-Type Plasminogen Activator Receptor as a Potential PET Biomarker in Glioblastoma.
Persson M; Nedergaard MK; Brandt-Larsen M; Skovgaard D; Jørgensen JT; Michaelsen SR; Madsen J; Lassen U; Poulsen HS; Kjaer A
J Nucl Med; 2016 Feb; 57(2):272-8. PubMed ID: 26429955
[TBL] [Abstract][Full Text] [Related]
16. Experimental Curative Fluorescence-guided Surgery of Highly Invasive Glioblastoma Multiforme Selectively Labeled With a Killer-reporter Adenovirus.
Yano S; Miwa S; Kishimoto H; Toneri M; Hiroshima Y; Yamamoto M; Bouvet M; Urata Y; Tazawa H; Kagawa S; Fujiwara T; Hoffman RM
Mol Ther; 2015 Jul; 23(7):1182-1188. PubMed ID: 25896244
[TBL] [Abstract][Full Text] [Related]
17. PET/NIR-II fluorescence imaging and image-guided surgery of glioblastoma using a folate receptor α-targeted dual-modal nanoprobe.
Shi X; Xu P; Cao C; Cheng Z; Tian J; Hu Z
Eur J Nucl Med Mol Imaging; 2022 Nov; 49(13):4325-4337. PubMed ID: 35838757
[TBL] [Abstract][Full Text] [Related]
18. Integrin αvβ3-targeted IRDye 800CW near-infrared imaging of glioblastoma.
Huang R; Vider J; Kovar JL; Olive DM; Mellinghoff IK; Mayer-Kuckuk P; Kircher MF; Blasberg RG
Clin Cancer Res; 2012 Oct; 18(20):5731-40. PubMed ID: 22914772
[TBL] [Abstract][Full Text] [Related]
19. Structurally symmetric near-infrared fluorophore IRDye78-protein complex enables multimodal cancer imaging.
Yang J; Zhao C; Lim J; Zhao L; Tourneau RL; Zhang Q; Dobson D; Joshi S; Pang J; Zhang X; Pal S; Andreou C; Zhang H; Kircher MF; Schmitthenner H
Theranostics; 2021; 11(6):2534-2549. PubMed ID: 33456558
[No Abstract] [Full Text] [Related]
20. Imaging the urokinase plasminongen activator receptor in preclinical breast cancer models of acquired drug resistance.
LeBeau AM; Sevillano N; King ML; Duriseti S; Murphy ST; Craik CS; Murphy LL; VanBrocklin HF
Theranostics; 2014; 4(3):267-79. PubMed ID: 24505235
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]